Health Canada drug identification number

DIN 02380048 — TOVIAZ 8 MG

TOVIAZ is a tablet (extended-release) of Fesoterodine marketed by PFIZER CANADA ULC. The full Fesoterodine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02380048
Brand name
TOVIAZ
Active ingredient
Fesoterodine
Strength
8 MG
Dosage form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Antimuscarinic (anticholinergic) agent for overactive bladder

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fesoterodine products

DINBrandStrengthFormManufacturerStatus
02535998 ACH-FESOTERODINE 4 MG TABLET (EXTENDED-RELEASE) ACCORD HEALTHCARE INC MARKETED
02536005 ACH-FESOTERODINE 8 MG TABLET (EXTENDED-RELEASE) ACCORD HEALTHCARE INC MARKETED
02521768 SANDOZ FESOTERODINE FUMARATE 4 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02521776 SANDOZ FESOTERODINE FUMARATE 8 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02380021 TOVIAZ 4 MG TABLET (EXTENDED-RELEASE) PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.